IMAGINOSTICS, INC.

Biotechnology · ORLANDO, FL

BiotechnologySEC Form D

IMAGINOSTICS, INC. filed a Form D with the U.S. Securities and Exchange Commission on April 3, 2026 for a private securities offering.

Incorporated in Delaware and based in ORLANDO, FL, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that IMAGINOSTICS, INC. has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Valerie Aimee GharagouzlooExecutive Officer · Director · Promoter
  • Codi Aimee GharagouzlooExecutive Officer · Director · Promoter
  • Scott HogeExecutive Officer

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
$10.0MRaised

Senti Biosciences Holdings, Inc.

BiotechnologySouth San Francisco, CA
IMAGINOSTICS, INC. raised $400.0K — SEC Form D